Efficiacy and safety of Bronchial Thermoplasty, when applied also in the Middle Lobe Bronchus

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011550

Enrollment

Registered

2017-04-03

Start date

2017-03-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J45.9

Interventions

Group 1: Patients with severe and poorly controlled bronchial Asthma receive bronchoscopic radio frequency ablation (RFA), called Bronchial Thermoplasty. Historically the Treatment protocol leaves out

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Severe and uncontrolled bronchial asthma

Exclusion criteria

Exclusion criteria: Contraindications of bronchoscopy and radiofrequency ablation

Design outcomes

Primary

Measure	Time frame
Safety of BT including the middle lobe bronchus	—

Secondary

Measure	Time frame
Pulmonary function (bodyplethysmography), Quality of Life (AQLQ-Asthma Quality of Life Questionnaire), dosage of orale corticosteroids, treatment complications, asthma exacerbations before and after Bronchial Thermoplasty	—

Countries

Germany

Contacts

Public ContactStephan Eisenmann

Universität EssenKlinik für Pneumologie, Abteilung Interventionelle Pneumologie

stephan.eisenmann@uk-essen.de+49-201-4334219

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026